Idorsia (Switzerland) Today
| IDIA Stock | CHF 0.84 0.07 9.09% |
Performance0 of 100
| Odds Of DistressOver 58
|
Idorsia is selling for under 0.84 as of the 25th of November 2024; that is 9.09 percent increase since the beginning of the trading day. The stock's lowest day price was 0.77. Idorsia has over 58 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Idorsia are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland. The company has 187.56 M outstanding shares. More on Idorsia
Moving together with Idorsia Stock
Moving against Idorsia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Idorsia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Idorsia's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Idorsia or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Idorsia (IDIA) is traded on SIX Swiss Exchange in Switzerland and employs 11 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Idorsia's market, we take the total number of its shares issued and multiply it by Idorsia's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Idorsia operates under Healthcare sector and is part of Biotechnology industry. The entity has 187.56 M outstanding shares.
Idorsia has accumulated about 811.85 M in cash with (859.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Idorsia Probability Of Bankruptcy
Ownership AllocationIdorsia has a total of 187.56 Million outstanding shares. Idorsia secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Idorsia Ownership Details
Idorsia Risk Profiles
Although Idorsia's alpha and beta are two of the key measurements used to evaluate Idorsia's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.1 | |||
| Standard Deviation | 4.47 | |||
| Variance | 19.97 | |||
| Risk Adjusted Performance | (0.25) |
Idorsia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Idorsia without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Idorsia Corporate Management
Elected by the shareholders, the Idorsia's board of directors comprises two types of representatives: Idorsia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Idorsia. The board's role is to monitor Idorsia's management team and ensure that shareholders' interests are well served. Idorsia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Idorsia's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Simon Jose | Ex Officer | Profile | |
| Andrew Weiss | Sr Communications | Profile | |
| Olivier Lambert | Sr Assurance | Profile | |
| Christoph Boss | VP Chemistry | Profile | |
| Martine Clozel | Ex Officer | Profile | |
| JeanPaul MD | CEO Director | Profile | |
| Alexander Khatuntsev | VP HR | Profile |
Additional Tools for Idorsia Stock Analysis
When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.